The Latest

By ACRO AI/ML Committee Members: Tala Fakhouri, VP, AI & Digital Policy, Real-World Research, Parexel InternationalS (…)

The U.S. biopharmaceutical industry leads globally in the development of new medicines and remains at the forefront of s (…)

The ACRO Site Resource Grants are designed to serve as seed funding to help clinical research sites to test innovative s (…)

ACRO member companies have compiled a series of case studies that demonstrate how centralized monitoring identifies crit (…)

Episode 10: Trends in Risk-Based Monitoring and RBQM in Clinical Trials Join three subject-matter experts to help us wra (…)

Episode 9: Granting Access – Lessons from ACRO’s Site Grant Program In 2024, ACRO announced its D&I Site (…)

Episode 8: AI on the Prize How AI is Modernizing Clinical Operations In this week’s episode, Jonathan Norman (Director (…)

ACRO’s Site Resource Grants are designed to serve as seed funding to help clinical research sites explore innovative s (…)

Episode 7: The Impact of ICH E6(R3) – Sponsor and CRO Perspectives In ACRO and TransCelerate BioPharma’s lat (…)